Discover our findings and learn more about our trials.
See our pipeline for work planned and in progress
Discover our findings and learn more about our trials.
Human Studies
2025/01
HUMAN STUDY PUBLISHED
Efficacy and Safety of a Mixture of Microencapsulated Sodium Butyrate, Probiotics, and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome-A Randomized, Double-Blind, Placebo-Controlled Study.
2024/10
Osteo duo:
HUMAN STUDY PUBLISHED
The Effect of Lacticaseibacillus paracasei LPC100 and Lactiplantibacillus plantarum LP140 on Bone Mineral Density in Postmenopausal Women: A Multicenter, Randomized, Placebo-Controlled Study.
2024/01
IMMUNOVIR:
HUMAN STUDY PUBLISHED
IMMUNOVIR:
HUMAN STUDY PUBLISHED
The role of nutritional support with probiotics in outpatients with symptomatic acute respiratory tract infections: a multicenter, randomized, double‑blind, placebo‑controlled dietary study.
2023/07
2023/07
GASTRO ONE BC300:
HUMAN STUDY PUBLISHED
GASTRO ONE BC300:
HUMAN STUDY PUBLISHED
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
2023/07
2023/07
GASTRO ONE BI040:
HUMAN STUDY PUBLISHED
GASTRO ONE BI040:
HUMAN STUDY PUBLISHED
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
2023/07
2023/07
GASTRO ONE BC300:
HUMAN STUDY PUBLISHED
GASTRO ONE BC300:
HUMAN STUDY PUBLISHED
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
2023/07
2023/07
GASTRO ONE BI040:
HUMAN STUDY PUBLISHED
GASTRO ONE BI040:
HUMAN STUDY PUBLISHED
The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome—A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial.
2021/02
2021/02
GASTRO IBS-10:
HUMAN STUDY PUBLISHED
GASTRO IBS-10:
HUMAN STUDY PUBLISHED
The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
In-vitro and significant findings
2025/03
2025/03
NORDBIOTIC™:
COMPLETE GENOME SEQUENCE
Complete genome sequencing and probiotic trait analysis of Lacticaseibacillus rhamnosus LR110, a human stool isolate from the NORDBIOTIC collection.
2025/02
2025/02
NORDBIOTIC™ BI040:
COMPLETE GENOME SEQUENCE
NORDBIOTIC™ BI040:
COMPLETE GENOME SEQUENCE
Complete genome sequence of Bifidobacterium animalis subsp. lactis BI040, a probiotic strain with multiple health benefits from the NORDBIOTIC collection.
2024/11
NORDBIOTIC™ LU150:
COMPLETE GENOME SEQUENCE
Complete genome sequence of Limosilactobacillus reuteri LU150, a potential vitamin B12 producer from the NORDBIOTIC collection.
2024/11
NORDBIOTIC™ LP140:
COMPLETE GENOME SEQUENCE
NORDBIOTIC™ LP140:
COMPLETE GENOME SEQUENCE
Complete genome sequence of a potentially probiotic cheese isolate Lactiplantibacillus plantarum LP140 from the NORDBIOTIC collection.
2024/08
NORDBIOTIC™ LC130:
COMPLETE GENOME SEQUENCE
NORDBIOTIC™ LC130:
COMPLETE GENOME SEQUENCE
Whole-genome sequencing and characterization of human fecal isolate Lacticaseibacillus casei LC130 from NORDBIOTIC collection.
2024/02
NORDBIOTIC™ LPC100:
COMPLETE GENOME SEQUENCE
NORDBIOTIC™ LPC100:
COMPLETE GENOME SEQUENCE
Complete genome sequence of the probiotic Lacticaseibacillus paracasei LPC100 strain from NORDBIOTIC™ collection isolated from a human fecal sample.
2024/01
NORDBIOTIC™ strain:
MIXTURE FOR GLUTEN DIGESTION
NORDBIOTIC™ strain:
MIXTURE FOR GLUTEN DIGESTION
Lacticaseibacillus casei LC130 strain, Lacticaseibacillus paracasei LPC100 strain, Streptococcus salivarius ssp. thermophilus ST250 strain – composition reducing the immunoreactivity of gliadin peptides and the use of strains for the production of the composition. Polish patent application no. P.447563
2023/10
SCIENTIFIC RATIONAL OF STRAIN SELECTION FOR CHILDREN’S HEALTH
SCIENTIFIC RATIONAL OF STRAIN SELECTION FOR CHILDREN’S HEALTH
Complete genome sequence of Limosilactobacillus reuteri LU150, a potential vitamin B12 producer from the NORDBIOTIC collection.
2023/05
NORDBIOTIC™ BABY:
SCIENTIFIC RATIONAL OF STRAIN SELECTION
NORDBIOTIC™ BABY:
SCIENTIFIC RATIONAL OF STRAIN SELECTION
The effectiveness of selected lactobacillus and Bifidobacterium on infantile colic.
2023/05
CLINICAL RATIONAL – NORDBIOTIC™ 5 STRAIN COMBINATION
CLINICAL RATIONAL – NORDBIOTIC™ 5 STRAIN COMBINATION
The effectiveness of selected Lactobacillus and Bifidobacterium lactis BI040 strains for support the health.
2023/05
FEMAX: ENHANCING IRON ABSORPTION
FEMAX: ENHANCING IRON ABSORPTION
Development of a Multilayer Probiotic Tablet for Enhanced Iron Absorption: Harnessing the Potential of NORDBIOTIC™ LC130, LPC100.
2022/11
RESISTANCE OF NORDBIOTIC™ STRAINS TO SELEN
RESISTANCE OF NORDBIOTIC™ STRAINS TO SELEN
Selection of NORDBIOTIC™ strains resistant to selenomethionine.
2022/10
TARGET SHIELD NORDBIOTIC™:
PROTECTION OF MICROBIOME
TARGET SHIELD NORDBIOTIC™:
PROTECTION OF MICROBIOME
Development of specific NORDBIOTIC™ composition of strains for antibiotic therapy.